Novocure Income Tax Expense from 2010 to 2024

NVCR Stock  USD 31.54  0.56  1.74%   
Novocure Income Tax Expense yearly trend continues to be relatively stable with very little volatility. Income Tax Expense is likely to grow to about 16.1 M this year. During the period from 2010 to 2024, Novocure Income Tax Expense destribution of quarterly values had range of 19.3 M from its regression line and mean deviation of  6,182,126. View All Fundamentals
 
Income Tax Expense  
First Reported
2013-12-31
Previous Quarter
10.6 M
Current Value
M
Quarterly Volatility
3.3 M
 
Yuan Drop
 
Covid
Check Novocure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novocure's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.8 M, Interest Expense of 3.2 M or Selling General Administrative of 87.6 M, as well as many indicators such as Price To Sales Ratio of 2.96, Dividend Yield of 0.0 or PTB Ratio of 4.16. Novocure financial statements analysis is a perfect complement when working with Novocure Valuation or Volatility modules.
  
Check out the analysis of Novocure Correlation against competitors.
To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Latest Novocure's Income Tax Expense Growth Pattern

Below is the plot of the Income Tax Expense of Novocure over the last few years. It is Novocure's Income Tax Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novocure's overall financial position and show how it may be relating to other accounts over time.
Income Tax Expense10 Years Trend
Slightly volatile
   Income Tax Expense   
       Timeline  

Novocure Income Tax Expense Regression Statistics

Arithmetic Mean6,161,743
Geometric Mean2,692,915
Coefficient Of Variation114.24
Mean Deviation6,182,126
Median4,434,000
Standard Deviation7,039,073
Sample Variance49.5T
Range19.3M
R-Value0.60
Mean Square Error34.2T
R-Squared0.36
Significance0.02
Slope942,818
Total Sum of Squares693.7T

Novocure Income Tax Expense History

202416.1 M
202315.3 M
202210.7 M
20216.3 M
2020-1.7 M
2019-1.6 M
201817.6 M

About Novocure Financial Statements

Novocure shareholders use historical fundamental indicators, such as Income Tax Expense, to determine how well the company is positioned to perform in the future. Although Novocure investors may analyze each financial statement separately, they are all interrelated. The changes in Novocure's assets and liabilities, for example, are also reflected in the revenues and expenses on on Novocure's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Income Tax Expense15.3 M16.1 M

Additional Tools for Novocure Stock Analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.